Medicenna Prices 3,333,334 Unit Offering At $1.50/Unit
Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (NASDAQ:MDNA, TSX:MDNA), a clinical stage immunotherapy company, announced today that it has priced its previously-announced marketedMedicenna Therapeutics Corp.